您好, 歡迎來到化工儀器網(wǎng)! 登錄| 免費注冊| 產(chǎn)品展廳| 收藏商鋪|
當(dāng)前位置:> 供求商機(jī)> 利格列汀雜質(zhì) Linagliptin
利格列汀雜質(zhì) Linagliptin? 產(chǎn)品介紹:
隨貨提供:所有雜質(zhì)對照品均隨貨提供HPLC,NMR,MS圖譜及CoA證書。
雜質(zhì)定制服務(wù):我司有專業(yè)研發(fā)團(tuán)隊,可提供雜質(zhì)定制服務(wù),以zui大可能的滿足您對雜質(zhì)對照品的選購需求。
利格列汀雜質(zhì) Linagliptin? 產(chǎn)品信息請:
何 :phastandards
國產(chǎn)進(jìn)口品牌皆有銷售,部分雜質(zhì)長期備有庫存,可快速發(fā)貨。
雜質(zhì)列表:
中文名稱 | 英文名稱 |
利格列汀標(biāo)準(zhǔn)品 | Linagliptin |
利格列汀雜質(zhì)1 | 2-((R)-3-aminopiperidine-1-carbonyl)-N-((R)-1-(7-(but-2-yn-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-8-yl)piperidin-3-yl)benzamide |
利格列汀雜質(zhì)2 | (R)-7-(but-2-yn-1-yl)-8-(3-(1,3-dioxoisoindolin-2-yl)piperidin-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-1H-purine-2,6(3H,7H)-dione |
利格列汀雜質(zhì)3 | N-Phthalimide-linagliptin |
利格列汀雜質(zhì)4 | N1,N2-bis((R)-1-(7-(but-2-yn-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-8-yl)piperidin-3-yl)phthalamide |
利格列汀雜質(zhì)5 | (R)-2-((1-(7-(but-2-yn-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-8-yl)piperidin-3-yl)carbamoyl)benzoic acid |
利格列汀雜質(zhì)6 | 8-((R)-3-aminopiperidin-1-yl)-7-((R)-buta-1,2-dien-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-1H-purine-2,6(3H,7H)-dione compound with 8-((R)-3-aminopiperidin-1-yl)-7-((S)-buta-1,2-dien-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-1H-purine-2,6(3H,7H)-dione (1:1) |
利格列汀雜質(zhì)7 | Linagliptin Diene Impurity |
利格列汀雜質(zhì)8 | Linagliptin Acetamide |
利格列汀雜質(zhì)9 | (R)-tert-butyl (1-(1,7-di(but-2-yn-1-yl)-3-methyl-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-8-yl)piperidin-3-yl)carbamate |
利格列汀雜質(zhì)10 | (R)-8-(3-aminopiperidin-1-yl)-1,7-di(but-2-yn-1-yl)-3-methyl-1H-purine-2,6(3H,7H)-dione |
利格列汀雜質(zhì)11 | 8-bromo-3-methyl-7-((4-methylquinazolin-2-yl)methyl)-1H-purine-2,6(3H,7H)-dione |
利格列汀雜質(zhì)12 | (R)-tert-butyl (1-(3-methyl-7-((4-methylquinazolin-2-yl)methyl)-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-8-yl)piperidin-3-yl)carbamate |
利格列汀雜質(zhì)13 | (R)-8-(3-aminopiperidin-1-yl)-3-methyl-7-((4-methylquinazolin-2-yl)methyl)-1H-purine-2,6(3H,7H)-dione |
利格列汀雜質(zhì)14 | (R)-7-(but-2-yn-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-8-(piperidin-3-ylamino)-1H-purine-2,6(3H,7H)-dione |
利格列汀雜質(zhì)15 | (R)-N-(1-(7-(but-2-yn-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-8-yl)piperidin-3-yl)-2,2,2-trifluoroacetamide |
利格列汀雜質(zhì)16 | (S)-8-(3-aminopiperidin-1-yl)-7-(but-2-yn-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-1H-purine-2,6(3H,7H)-dione |
利格列汀雜質(zhì)17 | (S)-Linagliptin |
利格列汀雜質(zhì)18 | N-(2-acetylphenyl)-2-(8-bromo-7-(but-2-yn-1-yl)-3-methyl-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-1-yl)acetamide |
利格列汀雜質(zhì)19 | (R)-tert-butyl (1-(1-(2-((2-acetylphenyl)amino)-2-oxoethyl)-7-(but-2-yn-1-yl)-3-methyl-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-8-yl)piperidin-3-yl)carbamate |
利格列汀雜質(zhì)20 | (R)-N-(2-acetylphenyl)-2-(8-(3-aminopiperidin-1-yl)-7-(but-2-yn-1-yl)-3-methyl-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-1-yl)acetamide |
利格列汀雜質(zhì)21 | (R)-tert-butyl (1-(7-(but-2-yn-1-yl)-3-methyl-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-8-yl)piperidin-3-yl)carbamate |
利格列汀雜質(zhì)22 | (R)-8-(3-aminopiperidin-1-yl)-7-(but-2-yn-1-yl)-3-methyl-1H-purine-2,6(3H,7H)-dione |
利格列汀雜質(zhì)23 | (S)-tert-butyl (1-(7-(but-2-yn-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-8-yl)piperidin-3-yl)carbamate |
利格列汀雜質(zhì)24 | (R)-7-(but-2-yn-1-yl)-8-(3-((7-(but-2-yn-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-8-yl)amino)piperidin-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-1H-purine-2,6(3H,7H)-dione |
利格列汀雜質(zhì)25 | (R)-N-(1-(7-(but-2-yn-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-8-yl)piperidin-3-yl)formamide |
深圳遠(yuǎn)揚化學(xué)除國產(chǎn)雜質(zhì)對照品外,代理有加拿大TLC雜質(zhì)對照品,TRC雜質(zhì)對照品,MC雜質(zhì)對照品,英國NIBSC標(biāo)準(zhǔn)品,美國CIL同位素標(biāo)準(zhǔn)品,NIST標(biāo)準(zhǔn)物質(zhì),歐洲標(biāo)準(zhǔn)局IRMM標(biāo)準(zhǔn)物質(zhì)等,原廠訂貨,質(zhì)量保證。
部分NIBSC標(biāo)準(zhǔn)品產(chǎn)品列表:
03/104-105 | HTLV-90 (antibody) Monitor Sample |
13/223 | Influenza Antigen B/Massachusetts/02/2101 (Egg derived) |
13/184 | C-Peptide, Human. 39st International Standard. |
10/111 | Reteplase Reference Material |
13/176 | C-Peptide, Human. 31st International Standard. |
13/264 | Polio Anti Sabin type 47 (inactivated) Serum |
13/239 | Polio Anti Sabin type 22 (inactivated) Serum |
13/265 | Polio Anti Sabin type 48 (inactivated) Serum |
95/659 | Interleukin-120 (Human, rDNA derived) |
13/189 | Influenza Antigen B/Massachusetts/02/2067 (Egg derived) |
01/447 | Meningococcal serogroup W polysaccharide |
13/151 | C-Peptide, Human. 6st International Standard. |
13/150 | C-Peptide, Human. 5st International Standard. |
10/134 | Reteplase Reference Material |
13/146 | C-Peptide, Human. 1st International Standard. |
95/616 | Interleukin-77 (Human, rDNA derived) |
07/359 | BCG Vaccine of Russian BCG-I sub-strain(86st WHO Reference Reagent) |
13/243 | C-Peptide, Human. 98st International Standard. |
07/290 | BCG Vaccine of Russian BCG-I sub-strain(17st WHO Reference Reagent) |
03/104-032 | HTLV-17 (antibody) Monitor Sample |
03/104-039 | HTLV-24 (antibody) Monitor Sample |
95/563 | Interleukin-24 (Human, rDNA derived) |
13/164 | Influenza Antigen B/Massachusetts/02/2042 (Egg derived) |
12/B623-068 | QCRFLUAH1N1QC1-Influenza AH1N1 QC66 |
07/292 | BCG Vaccine of Russian BCG-I sub-strain(19st WHO Reference Reagent) |
請輸入賬號
請輸入密碼
請輸驗證碼
以上信息由企業(yè)自行提供,信息內(nèi)容的真實性、準(zhǔn)確性和合法性由相關(guān)企業(yè)負(fù)責(zé),化工儀器網(wǎng)對此不承擔(dān)任何保證責(zé)任。
溫馨提示:為規(guī)避購買風(fēng)險,建議您在購買產(chǎn)品前務(wù)必確認(rèn)供應(yīng)商資質(zhì)及產(chǎn)品質(zhì)量。